Arcturus Therapeutics Holdings (ARCT) Other Working Capital Changes (2018 - 2026)
Arcturus Therapeutics Holdings' (ARCT) quarterly Other Working Capital Changes came in at -$636000.0 in Q1 2026, up 93.52% YoY from -$328645.8 in Q1 2025, and up 96.93% on a QoQ basis from -$20.7 million in Q4 2025.
Analysis
Arcturus Therapeutics Holdings (ARCT) Other Working Capital Changes (2018 - 2026) Analysis & Trends
Arcturus Therapeutics Holdings (ARCT) has 9 years of Other Working Capital Changes data on file, last reported at -$636000.0 in Q1 2026.
- Quarterly Other Working Capital Changes rose 93.52% year-over-year to -$636000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$14.7 million (up 77.06% YoY) and the FY2025 annual result came in at -$23.9 million, up 56.76% from the prior year.
- Other Working Capital Changes grew to -$636000.0 in Q1 2026, from -$20.7 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $4.2 million in Q3 2023 to a low of -$4.5 million in Q1 2023.
- A 5-year average of -$55176.5 and a median of -$163000.0 in 2023 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes plunged 2236.52% — and 2023, when it surged 2424.27%.
- Tracing ARCT's Other Working Capital Changes over 5 years: stood at -$11.2 million in 2022, then jumped by 141.41% to $4.6 million in 2023, then sank by 1231.1% to -$52.6 million in 2024, then jumped by 60.54% to -$20.7 million in 2025, then jumped by 96.93% to -$636000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$636000.0 (Q1 2026), -$20.7 million (Q4 2025), and $9.0 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Arcturus Therapeutics Holdings | 449.65 Mn | 258.17 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.33 Mn |
| Jun 30, 2026 | -1.33 Mn |
| Mar 31, 2026 | -636,000.00 |
| Mar 31, 2026 | -636,000.00 |
| Dec 31, 2025 | -2.80 Mn |
| Dec 31, 2025 | -2.80 Mn |
| Sep 30, 2025 | -8.99 Mn |
| Sep 30, 2025 | -8.99 Mn |
| Jun 30, 2025 | -2.27 Mn |
| Jun 30, 2025 | -2.27 Mn |
| Mar 31, 2025 | -9.82 Mn |
| Mar 31, 2025 | -9.82 Mn |
| Dec 31, 2024 | -8.16 Mn |
| Dec 31, 2024 | -8.16 Mn |
| Sep 30, 2024 | -13.43 Mn |
| Sep 30, 2024 | -13.43 Mn |
| Jun 30, 2024 | -29.61 Mn |
| Jun 30, 2024 | -29.61 Mn |
| Mar 31, 2024 | -4.01 Mn |
| Mar 31, 2024 | -4.01 Mn |